Clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology.

Sectors
Healthcare
Life Sciences
First Invested
2019
Public/PIPES
Company Status
IPO/Public
NASDAQ: IVA